The strategic acquisition contributes to the organic growth of the number of ACTO customers in the top 50 pharmaceutical industry

KISSIMMEE, FL., June 11, 2024 /CNW/ – Today at the Life Sciences Trainers & Educators Network (LTEN) annual conference, ACTO, the only AI-powered Intelligent Field Excellence (IFE) platform built specifically for the life sciences industry, announced the acquisition of 4th Down Solutions (4DS), a leading provider innovative mobile technologies and data-driven educational solutions for biopharmaceutical companies. Founded in 2010, 4DS has revolutionized the industry with its technology and approach, transforming commercial training from one-off exercises to a continuous learning technique to impact sales results in the field.

“Our long-standing strategic partnership with 4DS has been essential to helping Encompass Communications and Learning increase training engagement, provide insightful metrics and enable customers like Teva Pharmaceuticals to lead the industry and improve patients’ lives,” he said Jon MaddenManaging Partner at Encompass.

“We look forward to how our partnership with Encompass, strengthened by the ACTO platform and expanded capabilities, will enable the Teva sales team to make an even greater impact,” he said Jon MillerSenior Vice President of Innovative Drug Sales and Field Operations at Teva Pharmaceuticals.

“4DS was a pioneer in the evolution of commercial learning in the life sciences industry,” he said Parth Khanna, Director General of ACTO. “4DS has challenged the industry to change the way it thinks about field training, making continuous, personalized learning based on data analytics the new norm. With the path paved by 4DS and ACTO’s focus on expanding the way pharma is supported in the field with Intelligent Field Excellence, the combination of these two companies was a very natural fit.”

“We are delighted to join forces with ACTO as the benefits it offers both our customers and employees with a broader, intelligent solution for field excellence are unmatched in the industry,” he said Brett Howell, CEO of 4th Down Solutions. “ACTO is leading field force efficiency in life sciences through innovations in data analytics and artificial intelligence. We are excited to make this available to our customers.”

For more information visit

About ACTO
ACTO is an AI-powered Intelligent Field Excellence (IFE) platform built for life sciences that helps sales, marketing and medical teams improve customer engagement and brand performance by transforming field specialists into “message champions” who engage healthcare professionals and their support teams with authority and influence. With ACTO, biopharmaceutical companies can ensure that field professionals are always competent, confident and credible, delivering the right message to healthcare workers while providing senior leaders and front-line managers with the knowledge they need to continually improve the effectiveness of their field forces.

© 2024 ACTO Technologies, Inc. | Only the Intelligent Field Excellence (IFE) platform built specifically for life sciences. All rights reserved. All product and service names are the property of their respective owners.


View original content to download multimedia:

SOURCE ACTO Technologies, Inc.


View original content to download media: